Clinical Trial Update: Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether rimonabant influences atherosclerosis progression, as measured by carotid intima-media thickness, in patients with obesity an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Carotid Artery Plaque, Arteriosclerosis | Phase 3 | Status: TERMINATED